Gökçe joined from the pharmaceutical industry where she held global positions in Medical Affairs. She worked at the Karolinska Institute for 10 years, where she completed her PhD and postdoc. In 2021, she won the prestigious SSE MBA Carl Silfvén Scholarship allowing her to pursue her Executive MBA at Stockholm School of Economics. She is also the recipient of prestigious awards in the field of medical innovation. Gökçe is based in Stockholm.
Lovisa is a Medical Doctor and holds a PhD in clinical epidemiology from the Karolinska Institute. Prior to joining Eir Ventures, Lovisa served as Head of Business Development at the Swedish healthcare provider Capio, where she played a key role in setting the strategic direction and leading growth projects. Lovisa also gained valuable experience as a management consultant at Boston Consulting Group, working mainly in MedTech and Pharma. Lovisa is based in Stockholm.
Tobias is a physician and holds a BA in Law. Tobias started his career working as a physician in the clinic and later transferred to the pharmaceutical industry, where he spent several years in various regional and global leadership positions for Sanofi Genzyme and Y-mAbs. Tobias is experienced within rare diseases, immunology and oncology, developing and managing strategy, product launches and drug positioning with R&D. Tobias is also the founder of a medtech startup company, Connect2Treat.com, that digitalises HCP and pharma interactions. Tobias is based in Copenhagen.
Stephan has a PhD in Protein Chemistry and immunology from the Technical University of Denmark and UCSF. Stephan has broad executive experience from private as well as public biotech companies with responsibilities for R&D, operations, clinical development and corporate strategy. Stephan was a founding member of the early investment and company creation team Novo Seeds at Novo Holdings and has worked in life science venture capital as an active company creator and early investor for almost 20 years. His investments have mainly focused on the Nordic area, where Stephan has led the creation and funding of more than 30 companies. Stephan is based in Copenhagen.
Magnus is a Physician and Scientist, who early in his career successfully started a medical technology company (Aerocrine) and sold it, joined Sanofi and subsequently has been a Partner at two life science Venture Capital firms, HealthCap in Stockholm and The Column Group in San Francisco. He has had a role in dozens of investments and exits. Lately he has been an independent Chairman/Board member in several private and public companies in the Nordics, as well as in the US, and worked on a weekly basis as a clinician. Magnus has been actively involved in a number of successful pharma spin-outs. He has experience from the academic incubator space as CEO at Karolinska Institutet Holding. Magnus is based in Stockholm.
Amanda is a Molecular Biologist and has spent nearly 20 years on the business side with a focus on company building, venture investment, executive leadership, finance and business development. Amanda has been a co-founder of and operator within several academic and pharma-sourced spin-outs, and for a number of the spin-outs has taken interim executive management roles. Amanda’s venture experience comes from being a partner-level member of two US based venture funds, with an international investment scope, Baxalta Ventures and Connecticut Innovations. Amanda has board level and operational experience in the US and Europe, including in the Nordics. Amanda is based in the US.